Toggle navigation
Search
Tree View
MeSH on Demand
MeSH 2024
About
Suggestions
Contact Us
Insulins
MeSH Descriptor Data 2025
Details
Qualifiers
MeSH Tree Structures
Concepts
MeSH Heading
Insulins
Tree Number(s)
D06.472.699.587.200
D12.644.548.586.200
Unique ID
D061385
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D061385
Annotation
general or unspecified; prefer specifics
Scope Note
Peptide hormones that cause an increase in the absorption of
GLUCOSE
by cells within organs such as
LIVER
;
MUSCLE
and
ADIPOSE TISSUE
. During normal metabolism insulins are produced by the
PANCREATIC BETA CELLS
in response to increased
GLUCOSE
. Natural and chemically-modified forms of insulin are also used in the treatment of
GLUCOSE METABOLISM DISORDERS
such as
DIABETES MELLITUS
.
Registry Numbers
0
Public MeSH Note
2012
History Note
2012
Date Established
2012/01/01
Date of Entry
2011/06/24
Revision Date
2020/02/05
Allowable Qualifiers
administration & dosage (AD)
adverse effects (AE)
agonists (AG)
analysis (AN)
antagonists & inhibitors (AI)
biosynthesis (BI)
blood (BL)
cerebrospinal fluid (CF)
chemical synthesis (CS)
chemistry (CH)
classification (CL)
deficiency (DF)
economics (EC)
genetics (GE)
history (HI)
immunology (IM)
isolation & purification (IP)
metabolism (ME)
pharmacokinetics (PK)
pharmacology (PD)
physiology (PH)
poisoning (PO)
radiation effects (RE)
standards (ST)
supply & distribution (SD)
therapeutic use (TU)
toxicity (TO)
urine (UR)
Hormones, Hormone Substitutes, and Hormone Antagonists [D06]
Hormones [D06.472]
Peptide Hormones [D06.472.699]
Pancreatic Hormones [D06.472.699.587]
Insulins [D06.472.699.587.200]
Biphasic Insulins [D06.472.699.587.200.200]
Insulin, Long-Acting [D06.472.699.587.200.300]
Insulin, Short-Acting [D06.472.699.587.200.400]
Proinsulin [D06.472.699.587.200.500]
Islet Amyloid Polypeptide [D06.472.699.587.334]
Pancreatic Polypeptide [D06.472.699.587.700]
Proglucagon [D06.472.699.587.730]
Somatostatin [D06.472.699.587.780]
Amino Acids, Peptides, and Proteins [D12]
Peptides [D12.644]
Peptide Hormones [D12.644.548]
Pancreatic Hormones [D12.644.548.586]
Insulins [D12.644.548.586.200]
Biphasic Insulins [D12.644.548.586.200.200]
Insulin, Long-Acting [D12.644.548.586.200.300]
Insulin, Short-Acting [D12.644.548.586.200.400]
Proinsulin [D12.644.548.586.200.500]
Islet Amyloid Polypeptide [D12.644.548.586.234]
Pancreatic Polypeptide [D12.644.548.586.700]
Proglucagon [D12.644.548.586.730]
Somatostatin [D12.644.548.586.780]
Expand All
Collapse All
Insulins
Preferred
Concept UI
M0557285
Registry Numbers
0
Scope Note
Peptide hormones that cause an increase in the absorption of
GLUCOSE
by cells within organs such as
LIVER
;
MUSCLE
and
ADIPOSE TISSUE
. During normal metabolism insulins are produced by the
PANCREATIC BETA CELLS
in response to increased
GLUCOSE
. Natural and chemically-modified forms of insulin are also used in the treatment of
GLUCOSE METABOLISM DISORDERS
such as
DIABETES MELLITUS
.
Terms
Insulins
Preferred Term
Term UI
T789898
Date
04/28/2011
LexicalTag
NON
ThesaurusID
NLM (2012)
page delivered in 0.16s